Temozolomide and Other Alkylating Agents in Glioblastoma TherapyHannah A. Strobel, Mike‐Andrew Westhoff|Biomedicines|2019Cited by 276
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cellsSebastian Hasslacher, Mike‐Andrew Westhoff|International Journal of Oncology|2018Cited by 15